Table 2.
Association of NSAID use with liver cancer risk, CPRD
Cases (n = 1195) No. |
Controls (n = 4640) No. |
Crude OR (95% CI)a | Adjusted OR (95% CI)b | ||
---|---|---|---|---|---|
NSAID use | |||||
0–1 prescriptions | 438 | 1886 | 1.00 (Ref) | 1.00 (Ref) | |
2+ prescriptions | 757 | 2754 | 1.24 (1.08–1.43) | 1.05 (0.88–1.24) | |
No. of prescriptions | |||||
2–9 | 297 | 1158 | 1.15 (0.97–1.37) | 1.01 (0.83–1.23) | |
10–19 | 139 | 432 | 1.46 (1.17–1.83) | 1.30 (1.00–1.69) | |
20–39 | 126 | 481 | 1.20 (0.96–1.52) | 0.97 (0.74–1.27) | |
≥40 | 195 | 683 | 1.33 (1.07–1.65) | 1.00 (0.77–1.31) | |
Ptrend | 0.03 | 0.81 | |||
Recency of NSAID use | |||||
0–1 prescriptions | 438 | 1886 | 1.00 (Ref) | 1.00 (Ref) | |
Current NSAID use | 449 | 1701 | 1.19 (1.01–1.39) | 0.98 (0.81–1.18) | |
No. of prescriptions | |||||
2–9 | 96 | 408 | 1.03 (0.81–1.32) | 0.86 (0.65–1.14) | |
10–19 | 85 | 300 | 1.28 (0.98––1.67) | 1.21 (0.89–1.64) | |
20–39 | 97 | 382 | 1.18 (0.91–1.52) | 0.94 (0.70–1.27) | |
≥ 40 | 171 | 611 | 1.32 (1.06–1.66) | 1.01 (0.77–1.33) | |
Ptrend | 0.04 | 0.89 | |||
0–1 prescriptions | 438 | 1886 | 1.00 (Ref) | 1.00 (Ref) | |
Past NSAID use | 308 | 1053 | 1.33 (1.12–1.59) | 1.15 (0.94–1.40) | |
No. of prescriptions | |||||
2–9 | 201 | 750 | 1.24 (1.02–1.50) | 1.11 (0.89–1.39) | |
10–19 | 54 | 132 | 1.93 (1.37–2.71) | 1.51 (1.02–2.23) | |
20–39 | 29 | 99 | 1.36 (0.88–2.10) | 1.09 (0.68–1.77) | |
≥ 40 | 24 | 72 | 1.60 (0.98–2.61) | 1.06 (0.61–1.87) | |
Ptrend | 0.04 | 0.95 | |||
Intensity of NSAID use | |||||
Time between first and last prescription: <2 years | |||||
0–1 prescriptions | 438 | 1886 | 1.00 (Ref) | 1.00 (Ref) | |
2+ prescriptions | 143 | 484 | 1.30 (1.05–1.61) | 1.16 (0.91–1.48) | |
No. of prescriptions | |||||
2–9 | 122 | 417 | 1.30 (1.03–1.63) | 1.18 (0.91–1.52) | |
10–19 | 17 | 54 | 1.39 (0.79–2.43) | 1.10 (0.57–2.10) | |
20–39 | 4 | 13 | 1.38 (0.43–4.39) | 1.19 (0.34–4.18) | |
≥ 40 | 0 | 0 | NA | NA | |
Ptrend | 0.08 | 0.35 | |||
Time between first and last prescription: 2–5 years | |||||
0–1 prescriptions | 438 | 1886 | 1.00 (Ref) | 1.00 (Ref) | |
2+ prescriptions | 170 | 579 | 1.30 (1.06–1.59) | 1.15 (0.91–1.45) | |
No. of prescriptions | |||||
2–9 | 69 | 284 | 1.07 (0.80–1.43) | 0.90 (0.65–1.25) | |
10–19 | 43 | 119 | 1.62 (1.12–2.35) | 1.66 (1.10–2.51) | |
20–39 | 42 | 123 | 1.55 (1.07–2.24) | 1.32 (0.86–2.00) | |
≥40 | 16 | 53 | 1.33 (0.74–2.38) | 1.16 (0.60–2.22) | |
Ptrend | 0.02 | 0.24 | |||
Time between first and last prescription: >5 years | |||||
0–1 prescriptions | 438 | 1886 | 1.00 (Ref) | 1.00 (Ref) | |
2+ prescriptions | 444 | 1691 | 1.19 (1.00–1.41) | 0.92 (0.75–1.14) | |
No. of prescriptions | |||||
2–9 | 106 | 457 | 1.05 (0.82–1.35) | 0.88 (0.66–1.17) | |
10–19 | 79 | 259 | 1.38 (1.04–1.83) | 1.14 (0.82–1.58) | |
20–39 | 80 | 345 | 1.05 (0.80–1.39) | 0.81 (0.58–1.11) | |
≥40 | 179 | 630 | 1.31 (1.04–1.64) | 0.95 (0.72–1.25) | |
Ptrend | 0.03 | 0.80 |
Abbreviations: CI = confidence interval; CPRD = Clinical Practice Research Datalink; OR = odds ratio.
Using conditional logistic regression to account for matching.
Using conditional logistic regression to account for matching, and additionally adjusted for body mass index, smoking status, alcohol-related disorders, hepatitis B or C virus infection, diabetes, rare metabolic disorders, and use of paracetamol, antidiabetic medications, and statins.